Background
Heart failure is a disease with one of the highest mortality rates in the Western world. 1 Heart failure patients have a poor prognosis, with a five-year mortality rate of 68.7% and a median survival time of 2.4 years. 2 Heart failure is also associated with reduced quality of life and frequent readmissions to hospital. 3 Recommendations have been developed by the European Cardiology Society (ECS) that guide the use of pharmacological and non-pharmacological interventions for patients with heart failure. 4, 5 Non-pharmacological interventions focus mainly on lifestyle changes and changes of behavior in everyday life and must be systematically incorporated into the treatment and rehabilitation of patients with heart failure. 5 These behavioral changes can be interpreted as a significant part of the individual's self-care and a component of their future health behavior. The readmission rate is high for patients with heart failure and this "might be an indicator for low self-care behavior". Self-care encompasses the actions aimed at maintaining physical stability, avoidance of the behaviors that can worsen the condition and detection of the early symptoms of deterioration. Translating non-pharmacological recommendations from the ECS means that patients should be giving increased attention to fluid intake, dietary salt intake and observation of symptoms. 3, [6] [7] [8] [9] Self-care requires the active involvement of the patient who takes responsibility for the care and treatment they receive and ensures that the recommendations given to them by the health care system are valid and current.
A Cochrane review has found that a reduction of dietary sodium intake is generally beneficial for cardiac patients. However, it also indicated that a reduced dietary sodium intake could be harmful for patients with heart failure and may potentially even increase the risk of mortality. 10 Few public health policies have been as widely endorsed for lowering cardiovascular disease (CVD) morbidity and mortality as dietary sodium restriction. 12 This policy can be dated back to Kempner's observation that extreme sodium restriction tempered the hypertensive crisis associated with renal insufficiency. 13 Subsequently, sodium restriction was gradually incorporated into the management of many patients with essential hypertension as an adjunct therapy to antihypertensive drugs.
14 Normal dietary salt intake in the Scandinavian population is reported to be six grams per day for women and nine grams per day for men. Both the European and American guidelines recommend a reduction of dietary sodium intake for patients with heart failure. The recommended levels of sodium intake have been two to three grams per day with further restriction (below two grams per day) to be considered in patients with moderate to severe heart failure. 13, 14 These recommendations are based on level C evidence, that is, expert consensus opinion and results from observational studies. However, some studies indicate that this might be harmful for patients; therefore a systematic review of the evidence is
needed. An initial search in the data bases CINAHL, JBI COnNECT+, DARE, PubMed, Cochrane
Library and PROSPERO showed that no systematic review exists on this topic, or is currently underway.
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Inclusion criteria

Types of participants
This review will consider studies that include adult patients (18 years or older) with heart failure, regardless of gender or ethnicity. Studies including children or pregnant women were excluded.
Types of intervention(s)/phenomena of interest
This review will consider studies that evaluate reduced dietary salt intake in patients with heart failure.
The comparators include usual dietary salt intake, control or placebo diet, or no intervention.
Types of outcomes
This review will consider studies that evaluate reduced dietary salt intake in patients with heart failure and the outcome will be cardiovascular morbidity and cardiovascular-related hospital admissions. 
Types of studies
This review will consider any experimental study design including randomized controlled trials, non-randomized controlled trials, quasi-experimental and before and after studies for inclusion.
Search strategy
The search strategy aims to find both published and unpublished studies. A three-step search strategy will be utilized in this review. An initial limited search of PubMed and CINAHL were undertaken, followed by analysis of the text words contained in the title and abstract and of the index terms used to describe the article. A second search using all identified keywords and index terms will then be undertaken across all included databases. Thirdly, the reference lists of all identified reports and articles will be searched for additional studies, as well as citation searches will be applied. Studies published in English, German, Danish, Swedish and Norwegian will be considered for inclusion in this review.
Databases will be searched from their inception to September 2013 and the selected studies will be considered for inclusion in this review.
The databases to be searched include:
PubMed, CINAHL, Embase, Scopus, Swemed+, Health Technology Assessment Database, Turning
Research Into Practice (TRIP) Database
Additional searching for published literature will include:
Hand searching the reference lists and bibliographies of included articles and any relevant systematic reviews identified in the Joanna Briggs Institute Library of Systematic Reviews and Cochrane Database of Systematic Reviews
The search for unpublished studies will include searches of the following databases and websites: dietary salt intake, heart failure, readmission
Assessment of methodological quality
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity prior to inclusion in the review, using standardized critical appraisal instruments from the Joanna Briggs
Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix V). Any disagreements that arise between the reviewers will be resolved through discussion, or with a third reviewer.
Data collection
Data will be extracted from the papers included in the review using the standardized data extraction tool from JBI-MAStARI (Appendix VI). The data extracted will include specific details about the interventions, populations, study methods and outcomes of significance to the review question and specific objectives. Data extraction will be compiled by a single reviewer and checked by a second.
Authors will be contacted where possible to obtain missing information.
Data synthesis
Quantitative data will, where possible, be pooled in statistical meta-analysis using JBI-MAStARI. All results will be subject to double data entry. Effect sizes expressed as odds ratios (for categorical data) and weighted mean differences (for continuous data) and their 95% confidence intervals will be calculated for analysis. Heterogeneity will be assessed statistically using the standard chi-square test.
Where statistical pooling is not possible, the findings will be presented in narrative form including tables and figures to aid in data presentation where appropriate.
Conflicts of interest
None
